West Family Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
977
-160
| -14% | -$84K | 0.13% | 155 |
|
|
2025
Q1 | $721K | Hold |
1,137
| – | – | 0.27% | 76 |
|
|
2024
Q4 | $810K | Sell |
1,137
-53
| -4% | -$37.8K | 0.28% | 71 |
|
|
2024
Q3 | $1.25M | Buy |
1,190
+5
| +0.4% | +$5.26K | 0.43% | 48 |
|
|
2024
Q2 | $1.25M | Buy |
1,185
+2
| +0.2% | +$2.1K | 0.37% | 55 |
|
|
2024
Q1 | $1.14M | Buy |
1,183
+46
| +4% | +$44.3K | 0.35% | 58 |
|
|
2023
Q4 | $999K | Hold |
1,137
| – | – | 0.34% | 60 |
|
|
2023
Q3 | $936K | Sell |
1,137
-204
| -15% | -$168K | 0.33% | 63 |
|
|
2023
Q2 | $964K | Hold |
1,341
| – | – | 0.37% | 60 |
|
|
2023
Q1 | $1.1M | Sell |
1,341
-30
| -2% | -$24.7K | 0.44% | 58 |
|
|
2022
Q4 | $989K | Sell |
1,371
-198
| -13% | -$143K | 0.34% | 63 |
|
|
2022
Q3 | $1.08M | Sell |
1,569
-71
| -4% | -$48.9K | 0.45% | 48 |
|
|
2022
Q2 | $969K | Sell |
1,640
-171
| -9% | -$101K | 0.38% | 54 |
|
|
2022
Q1 | $1.27M | Sell |
1,811
-17
| -0.9% | -$11.9K | 0.36% | 49 |
|
|
2021
Q4 | $1.15M | Sell |
1,828
-204
| -10% | -$129K | 0.31% | 56 |
|
|
2021
Q3 | $1.23M | Buy |
2,032
+228
| +13% | +$138K | 0.32% | 53 |
|
|
2021
Q2 | $1.01M | Buy |
+1,804
| New | +$1.01M | 0.27% | 52 |
|